KRISTA BELL: Open Payments
NPI 1255183349 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 68 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $375 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $381 |
| GlaxoSmithKline, LLC. | 18 | $261 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $149 |
| GENZYME CORPORATION | 4 | $123 |
| Amgen Inc. | 6 | $119 |
| CSL Behring | 3 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Genentech USA, Inc. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Cycle Pharmaceuticals Inc | 1 | $29 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, FASENRA, NEFFY, Xolair, AIRSUPRA, Xhance.
Industry payments across TN — which companies pay providers there.
